In patients with SSc, circulating type 2 conventional DCs (cDCs) exhibit increased production of IL-6, IL-10, and tumor necrosis factor-α (TNF-α) following stimulation with TLR2 and TLR4 (41, 42). This evidence concerns the gene IL6 and systemic sclerosis.